CRISPR Therapeutics AG

1CG.F·Frankfurt·Healthcare
Compare
45.57−0.43 (−0.93%)today
As of Nov 5, 8:18 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close46.00
Open45.57
Day range—
52-week range37.6055.00
Off day high0.00%
Off 52-week high−17.15%
Volume95.00
Avg. volume (3M)126
Market cap4.42B
EPS (TTM)-3.91
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.90
Shares outstanding97.00M
Short interest—
Earnings dateNov 2, 2026
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
1CG.F NTLA SANA EDIT SCTX PGEN
Market cap 4.42B 1.72B 766.36M 417.74M 317.67M 1.81B
P/E (TTM) — — — — — —
Forward P/E — -4.8 -4.6 -3.6 -4.6 -23.0
Price/book 3.0 2.4 5.0 4.0 -0.3 85.7
Dividend yield — — — — — —
1-year change −8.65% −12.60% −40.20% −6.47% −14.60% +31.58%
Today −0.93% +3.79% +4.92% +4.62% +3.58% −3.71%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 1CG.F news ›
MarketScreener··2 outletsPositive

Crispr Therapeutics Announces Appointment of Sivakesava Sakhamuri as Chief Technical Officer, Effective November 2, 2026

CRISPR Therapeutics announced the appointment of Sivakesava Sakhamuri, Ph.D., as Chief Technical Officer, effective November 2, 2026. Dr. Sakhamuri brings about 30 years of technical operations and... CRISPR Therapeutics announced the…

More from 1 other outlet
MarketScreener·Positive

CRISPR Therapeutics AG Announces CFO Changes

CRISPR Therapeutics AG announced the promotion of Andrew J. Silver, currently the Company's SVP, Finance, to be the Company's Chief Financial Officer effective October 19, 2026. Since January 2025,... CRISPR Therapeutics AG announced the…

From the 4Search news index, newest first.

In the news

62mentions in 30 days
62with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 62 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance